title: Gene Therapy to Cure HIV: Where to from Here?
abstract: A variety of approaches are being tested to cure HIV, but with the exception of the Berlin patient case, none has been successful. The Berlin patient, positive for both HIV and acute myeloid leukemia (AML), received two stem cell transplants from a donor homozygous for the CCR5delta32 mutation. In the 8 years since his second transplant, he has remained free of both HIV and AML. This case provides strong proof-of-principle that a cure for HIV is possible and might be achieved through gene therapy. Several technological barriers must be resolved and are discussed here, including the safe delivery of the intervention throughout the body of the infected person, increased efficiency of gene editing, and avoidance of resistance to the therapy. Delivery of a gene therapy intervention to HIV-infected people around the world will also be a considerable challenge.
authors.affiliation: Department of Research, amfAR, New York, New York.
authors.forename: Rowena
authors.initials: R
authors.lastname: Johnston
mesh_terms: D015316:Genetic Therapy; D015658:HIV Infections / Q000235:genetics / Q000628:therapy*; D015497:HIV-1 / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009154:Mutation; D019713:Receptors, CCR5 / Q000235:genetics; D014161:Transduction, Genetic
chemical_list: D019713:Receptors, CCR5
keywords: HIV; cure; gene therapy; in vivo targeting; transduction efficiency